IBD arrises due to
a breakdown of tolerance to own gut flora
Describe change in epithelial cells due to inflammatory damage
- give an example of disease
Inflammatory insult e.g. LPS = perturbation of epithelial cells
long crypts but villi destroyed therefore cant absorb nutrients = malnourishment
e.g. celiac disease
Chrons disease affects where
Which Th type & what cells involved
Ulcerative colitis disease affects where
Which Th type & what cells involved
- Blocking what is protective
Large intestine (colon) and rectum
Continuous inflammation in inner layer of colon lining
- Th2 via IL-13 production –> which drives fibrosis
- activation of mast cells, goblet & eosinophils
Results in mast cell hyperplasia and subsequent release of inflammatory mediators
Blocking IL-4Rα is protective (and receptor for IL-13)
What drives IBD
Environmental factors - smoking, antigens
Gut bacteria
- epithelial cell defect: loss of tight junction allows microbiome to enter
Abnormal immune response
- auto-antigens: cross reactivity w/ environmental antigens
Genetics
- MHC,
Summary: list 4 key points leading to IBD
why it happens & what does this eventually lead to
What happens to sterile mice (no maternal immunity)
Unable to develop MALT immune response
Name the below functions of the microflora
How do probiotic work
- name one
Compete w/ ~pathogenic bacteria
Treg induced to modulate immune response from Th1/th17 or Th2
Increased IgA secretion - upreg production of TGFb (by Tc & epithelial cells)
Digestion of lactose
- Lactococcus
Possible immunological intervention for the treatment of IBD (8)
Anti-inflammatory cytokines: IL-1ra, IL-10, IFN-a, TGF-B
Antibodies against cytokine: Anti-TNF-a, anti-IFN-y, anti-IL-12
Cytokine transcription: Anti-sense oligonucleotide against NF-kB
T helper cells: Anti-CD4
Antigen-specific: Anti-T-cell receptor (Car Tc therapy)
Adhesion molecules: Anti-sense oligonucleotide against ICAM-1, Ab against MAdCAM, a4B7
Non-specific inflammatory mediators: PGE1, leukotriene, thromboxane inhibitors or receptor antagonists, platelet activating factor antagonist, nitric oxide
Oral tolerance: Haptenised colonic proteins, Alter immunogenically & feed to problem- will restore oral tolerance, Hapten carrier effect (make it look diff to immune system)
Manipulation of luminal contents: Antibiotic treatment, probiotics, Fermented foods, Faecal transplant therapy
Name endogenous factors defects that may alter the antigenicity of luminal antigens and/or increase
intestinal permeability
defects to
gastric acid, proteolytic enzymes (can make antigens less antigenic)
anti-microbial molecules (defensins, cryptidins)
trefoil peptides, neuroendocrine system, substance P
Can early inflammation be reversed
Yes
What is the relationship between no. Of antibiotics kids prescribed & disruption to microbiome
Positive correlation
Cures pathogenic bacteria but also wipes out microbiome –> when restored will be a diff composition
Name mice models which dont get IBD
Germ free IL-2 KO, IL-10 KO, TCR-α KO, HLA-B27 tg
Describe macrobiotic change
Decrease diversity
Decrease firmicutes
Increase proteobacteria
Increase instability over time